Company intelligence / Profile preview
Xizang Weixinkang Pharmaceutical
Lhasa, Tibet/Xizang AR, Chinaen.wxkpharma.com ↗
- Ownership
- Private
- Employees
- ~701
- Development stage
- Other
01
Overview
Xizang Weixinkang Pharmaceutical is a leading Chinese pharmaceutical manufacturer specializing in parenteral nutrition solutions—including intravenous vitamins, trace elements, amino acids—and hospital injectables. The company has over a dozen subsidiaries across China and Asia-Pacific regions. It operates three major R&D technology platforms focused on new injection processes and large compound formulations. Its commercial portfolio includes multiple approved injectable products with ongoing expansion into additional hospital-focused medicines through partnerships.
- Therapeutic areas
- Metabolic DisordersPulmonologyEndocrinologyHematologyGastroenterology
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
AFT Pharmaceuticals – exclusive license to distribute Maxigesic IV in China since September 2024; regulatory approval process ongoing.Hyloris Pharmaceuticals – exclusive licensing agreement for Maxigesic IV for the Chinese market.Edge Pharmaceuticals – co-development of hospital injectable portfolio targeting global markets including Australia/NZ/Singapore/Hong Kong/South Africa/Canada/UK via affiliates of AFT Pharmaceuticals.
Beyond the preview
Go deeper on Xizang Weixinkang Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xizang Weixinkang Pharmaceutical.